Infection, vaccination and narcolepsy type 1: Evidence and potential molecular mechanisms

Area of Science:

• Neurology
• Immunology
• Sleep Medicine

Background:

• Narcolepsy type 1 (NT1) is a rare, chronic neurological disorder characterized by excessive daytime sleepiness and cataplexy.
• Pathologically, NT1 involves a significant loss of hypocretin (HCRT)/orexin-producing neurons in the lateral hypothalamus.
• While the precise cause of NT1 remains unknown, substantial evidence points towards an autoimmune etiology.

Purpose of the Study:

• To review the evidence linking infections and Pandemrix® vaccination to the pathogenesis of Narcolepsy type 1.
• To explore potential molecular mechanisms underlying the autoimmune response in NT1.
• To discuss these mechanisms in the context of other autoimmune diseases.

Main Methods:

• Literature review of studies on Narcolepsy type 1.
• Analysis of evidence supporting an autoimmune origin of NT1.
• Examination of potential triggers like infections and vaccination (Pandemrix®).
• Discussion of genetic susceptibility, particularly the HLA-DQB1*06:02 allele.

Main Results:

• Compelling evidence supports an autoimmune basis for NT1.
• Infections and Pandemrix® vaccination are implicated as potential triggers in genetically susceptible individuals (HLA-DQB1*06:02 carriers).
• The specific molecular pathways leading to HCRT neuron loss are still under investigation.

Conclusions:

• NT1 pathogenesis likely involves an immune-mediated destruction of HCRT neurons.
• Genetic predisposition (HLA-DQB1*06:02) plays a crucial role in developing NT1 following exposure to triggers like infections or vaccination.
• Further research is needed to fully elucidate the molecular mechanisms involved.